PET-MR Fusion Imaging and Surrogate Marker for Prediction and Monitoring of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
Observational Model: Case-Only, Time Perspective: Prospective
Change in the maximum dimension of the tumor over time
baseline, completion of 1st cycle of chemotherapy, and completion of 6th cycle of chemotherapy
Woo Kyung Moon, M.D., Ph.D.
Department of Radiology, Seoul National University Hospital
Korea: Ministry for Health, Welfare and Family Affairs
PET-MR Breast Cancer